Longevitas DAO funds and develops regenerative medicine therapies that target the root causes of aging, with a focus on senolytics, epigenetic reprogramming, and tissue rejuvenation.

NeuroGen DAO accelerates brain research by funding innovative therapeutic approaches to neurodegenerative diseases and cognitive decline through decentralized science.